Is Cetrorelix FDA approved?

Cetrorelix is FDA approved. This regulatory status is provided for research and educational context only.

Is Gonadorelin FDA approved?

Gonadorelin is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Cetrorelix administered in research settings?

In research settings, Cetrorelix is typically administered via the subcutaneous route. PeptideBase does not provide dosing or administration instructions.

How is Gonadorelin administered in research settings?

In research settings, Gonadorelin is typically administered via the subcutaneous or intravenous routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Cetrorelix vs Gonadorelin

Peptide Comparison

Cetrorelix vs Gonadorelin

Name: Cetrorelix vs Gonadorelin — Per-mg Price Comparison
Creator: PeptideBase
License: https://peptidebase.io/terms

Both are Reproductive & Hormonal peptides.

Cetrorelix

Cetrotide

Sexual HealthFDA ApprovedPrescription

Half-life: ~62 hours

1 providers listed

Full Cetrorelix profile →

Gonadorelin

GnRH

Sexual HealthNot EvaluatedCompoundable

Half-life: ~2-4 minutes

28 providers listed

Full Gonadorelin profile →

Bottom line

Cetrorelix is FDA-approved, while Gonadorelin is not evaluated — the clearest structural difference between them.

Quick Verdict

Cetrorelix

Half-life

~62 hours

Gonadorelin

Half-life

~2-4 minutes

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Cetrorelix
Further along in FDA review	Cetrorelix
Less frequent dosing (longer half-life)	Cetrorelix
More provider options (1 vs 28)	Gonadorelin

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Cetrorelix

Gonadorelin

Mechanism Family

Reproductive & Hormonal

Half-life

~62 hours

~2-4 minutes

FDA Status

approved

not evaluated

Admin Routes

subcutaneous

subcutaneous, intravenous

Availability

Prescription

Compoundable

Providers

1 listed

28 listed

Avail. Notes

FDA-approved GnRH antagonist. Brand: Cetrotide (NDA 021036, Jun 1999). Prevents premature LH surges in controlled ovarian stimulation. Prescription only.

Previously FDA-approved as Factrel (NDA 017019). Voluntarily discontinued by manufacturer. Included on the FDA 503B outsourcing-facility bulk-substances list (Category 1), not the 503A pharmacy list. Prescription compounded product.

Research Evidence

Cetrorelix

Meta-analysis · 7 key studies · most recent 2026

Gonadorelin

Meta-analysis · 3 key studies · most recent 2026

Research Citations

Cetrorelix

Meta-analysis2026 · J Coll Physicians Surg Pak

GnRH Agonists and Antagonists in IVF/ICSI Cycles of PCOS Women: A Network Meta-Analysis.

Meta-analysis2023 · Hum Reprod Update

Optimal GnRH antagonist protocol for ovarian stimulation during ART: systematic review and network meta-analy…

Cohort2026 · Int J Reprod Biomed

Efficacy and safety of different cetrorelix doses in the luteal phase for preventing ovarian hyperstimulation…

Cohort2021 · BMC Pregnancy and Childbirth

Effects of half-dose and full-dose GnRH antagonists on IVF-ET outcomes: a retrospective study

+3 more

Gonadorelin

Meta-analysis2018 · Fertility and Sterility

Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy among patients with idiopathic and fu…

Animal2026 · J Reprod Dev

Effect of post-insemination GnRH analogue administration on pregnancy rates in repeat-breeder cows: compariso…

Animal2026 · J Dairy Sci

Increasing gonadorelin hydrochloride dose at the first GnRH of breeding Ovsynch enhances luteinizing hormone…

About Cetrorelix

Competitive GnRH receptor antagonist; immediately blocks pituitary GnRH receptors; rapidly suppresses LH/FSH without initial flare effect; used for controlled hormonal suppression

Research Areas

HPG axis suppressionLH/FSH reductioncontrolled ovarian stimulation supporttestosterone management

About Gonadorelin

Synthetic GnRH that binds pituitary GnRH receptors; pulsatile dosing stimulates LH/FSH release; used to maintain HPG axis during TRT

Research Areas

pulsatile LH and FSH stimulation from the pituitarytesticular function and testosterone production maintenancefertility preservation alongside TRT (FSH pathway intact)hypothalamic-pituitary axis restoration in hypogonadism

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Cetrorelix

Absolute Contraindications

Pregnancy — contraindicatedLactation — contraindicated

Source: FDA label

Suggested Monitoring

Under clinical review

Being verified by our medical team before we display monitoring guidance for this peptide.

Gonadorelin

Reported (Unverified — Pending Clinical Review)

continuous high-dose (causes receptor downregulation)

No established clinical contraindications

Suggested Monitoring

Total testosteroneLHFSHEstradiol (E2)SHBGProlactin

Standard reproductive endocrinology panels establish HPG axis baseline. LH and FSH confirm pituitary response to gonadorelin; testosterone, E2, and SHBG reflect downstream gonadal output.

Price (per mg)

Cetrorelix

Not enough vendor pricing yet.

Gonadorelin

$12.49/mg

$8.05 – $24.50 range

13 vendors

View price index →Find providers →

Find Providers

Where to source these peptides

Providers offering

Cetrorelix

1 listed

Browse directory →

Providers offering

Gonadorelin

28 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Reproductive & Hormonal Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated October 28, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Cetrorelix vs Gonadorelin — Per-mg Price Comparison. Retrieved October 28, 2026, from https://peptidebase.io/peptides/compare/cetrorelix/gonadorelin

https://peptidebase.io/peptides/compare/cetrorelix/gonadorelin Methodology License Download JSON Download CSV